Replies to post #1006 on Conatus Pharmaceuticals Inc. (CNAT)

[fishhunter]

The CNAT market cap at the current stock price remains a joke for several reasons:

First, Almost all the risk is now gone from the stock due to Novartis.

Second, The drug results Conatus has published to date are obviously encouraging to anyone who can read, however, can you imagine the depth to which Novartis dug into things before writing a $50mil check and pledging another $800mil to $1bil?

Third, the market cap TODAY is even less than it was a couple years ago before the results, before Novartis, before about anything.

Fourth, Think about some of the upcoming catalysts and PRs we are likely to see with respect to milestones and trigger payments.

This will not stay in the $5 price range for very long. I will venture this gets to about $8 by the end of next week, $20 by late Summer.